Article Sidebar
Published:
Feb 15, 2024DOI:
10.4314/jpb.v21i1.2Keywords:
Article Details
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
In vitro studies on the antidiabetic and antibacterial activity of biosynthesized silver nanoparticles with aqueous extract of Moringa oleifera leaf
Abstract
Silver nanoparticles having applications in the field of medicine and biology are shown to have tremendous health benefits. Diabetes is still on rampage and antibacterial resistance is currently a global health challenge. This study focuses on the in-vitro antidiabetic and antibacterial activity of biosynthesized silver nanoparticles with aqueous extract of Moringa oleifera leaf. An aliquot (5 mL) of extract sample was added to 50 mL of 1 mM aqueous AgNO3. Reaction mixtures were heated and maintained at 700C for 10 minutes. Colour change to dark brown solution and a UV-vis spectrum peak at 400 nm confirmed silver nanoparticle synthesis. The antidiabetic activity of the nanoparticle was studied using an in vitro alpha-amylase inhibition assay. Acarbose was used as antidiabetic control drug. Disc diffusion method was used for antibacterial susceptibility testing on Mueller-Hinton agar medium with ampiclox as control antibiotic. Results of the analysis showed significant inhibition of alpha amylase that resembled the activity of acarbose. The highest percentage inhibition of alpha amylase by AgNPs was observed at 65.625% while that of acarbose was 90.357%. Antibacterial inhibition assay revealed that 100% biosynthesized silver nanoparticles had significant (p<0.05) inhibitory effects on Eschericia coli and Streptococcus pyogenes.
